NCT00927147View on ClinicalTrials.gov

Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Head and Neck Cancer
Interventions
RADIATION

BNCT

Boronophenylalanine infusion followed by neutron irradiation

DRUG

cetuximab

cetuximab infusion 250 to 400 mg/kg intravenously, 1 to 3 infusions

Trial Locations (1)

FIN-00029

Department of Oncology, Helsinki University Central Hospital, Helsinki

Sponsors

Lead Sponsor

Boneca Corporation
All Listed Sponsors
lead

Boneca Corporation

INDUSTRY

NCT00927147 - Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer | Biotech Hunter | Biotech Hunter